HEAR YOUR HEART Trademark

Trademark Overview


On Wednesday, December 8, 2021, a trademark application was filed for HEAR YOUR HEART with the United States Patent and Trademark Office. The USPTO has given the HEAR YOUR HEART trademark a serial number of 97163221. The federal status of this trademark filing is REGISTERED as of Tuesday, August 8, 2023. This trademark is owned by Boehringer Ingelheim Pharmaceuticals, Inc.. The HEAR YOUR HEART trademark is filed in the Advertising, Business and Retail Services and Medical & Beauty Services & Agricultural Services categories with the following description:

promotional services by manufacturers of heart and diabetes pharmaceutical products, namely, promoting awareness of heart failure in women and its symptoms, treatment and prevention

providing information by manufacturers of heart and diabetes pharmaceutical products on heart failure in women and its symptoms, treatment and prevention
hear your heart

General Information


Serial Number97163221
Word MarkHEAR YOUR HEART
Filing DateWednesday, December 8, 2021
Status700 - REGISTERED
Status DateTuesday, August 8, 2023
Registration Number7134392
Registration DateTuesday, August 8, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 8, 2022

Trademark Statements


Description of MarkThe mark consists of the wording "HEAR YOUR" depicted in blue and situated above the word "HEART" depicted in larger red lettering, with the "A" in "HEART" appearing as a heart design with two sound waves on each side of the bottom of the heart, and with the interior of the heart depicted in white.
Indication of Colors claimedThe color(s) red, blue and white is/are claimed as a feature of the mark.
Goods and Servicespromotional services by manufacturers of heart and diabetes pharmaceutical products, namely, promoting awareness of heart failure in women and its symptoms, treatment and prevention
Goods and Servicesproviding information by manufacturers of heart and diabetes pharmaceutical products on heart failure in women and its symptoms, treatment and prevention

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, October 6, 2022
Primary Code035
First Use Anywhere DateWednesday, April 20, 2022
First Use In Commerce DateWednesday, April 20, 2022

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 6, 2022
Primary Code044
First Use Anywhere DateWednesday, April 20, 2022
First Use In Commerce DateWednesday, April 20, 2022

Trademark Owner History


Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877

Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877

Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877

Trademark Events


Event DateEvent Description
Tuesday, August 8, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 8, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, July 4, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, July 1, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 28, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 1, 2023USE AMENDMENT FILED
Wednesday, June 28, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 1, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, January 3, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 6, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, October 6, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 6, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, October 6, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, September 29, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, September 29, 2022FINAL REFUSAL E-MAILED
Thursday, September 29, 2022FINAL REFUSAL WRITTEN
Tuesday, August 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 13, 2022NON-FINAL ACTION E-MAILED
Wednesday, April 13, 2022NON-FINAL ACTION WRITTEN
Monday, April 11, 2022ASSIGNED TO EXAMINER
Wednesday, December 15, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, December 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 11, 2021NEW APPLICATION ENTERED